[{"address1": "1400 Sierra Point Parkway", "address2": "Building C Suite 200", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "650 822 5500", "fax": "650 636 9773", "website": "https://www.annexonbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company's lead candidate is ANX005, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barr\u00e9 syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. The company is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.", "fullTimeEmployees": 103, "companyOfficers": [{"maxAge": 1, "name": "Mr. Douglas E. Love Esq., J.D.", "age": 56, "title": "CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 1010807, "exercisedValue": 0, "unexercisedValue": 446927}, {"maxAge": 1, "name": "Dr. Ted  Yednock Ph.D.", "age": 66, "title": "Executive VP, Chief Innovation Officer & Chairman of the Scientific Advisory Board", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 714668, "exercisedValue": 0, "unexercisedValue": 175585}, {"maxAge": 1, "name": "Dr. Jamie  Dananberg M.D.", "age": 66, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 715233, "exercisedValue": 0, "unexercisedValue": 154858}, {"maxAge": 1, "name": "Ms. Jennifer  Lew CPA", "age": 51, "title": "Executive VP, CFO & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 624195, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Dr. Dean R. Artis Ph.D.", "age": 63, "title": "Chief Scientific Officer & Executive VP", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 797380, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Overdorf M.B.A.", "age": 54, "title": "Executive VP & Chief Business Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 580469, "exercisedValue": 0, "unexercisedValue": 13124}, {"maxAge": 1, "name": "Mr. Henk-Andre  Kroon M.D.", "title": "Senior Vice President of Translational Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shikhar  Agarwal M.B.A.", "title": "Senior VP & Head of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sunil  Mehta Pharm.D.", "title": "Senior VP of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lloyd  Clark M.D.", "title": "Senior Vice President of Ophthalmology Strategy & Innovation", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.55, "open": 2.52, "dayLow": 2.41, "dayHigh": 2.565, "regularMarketPreviousClose": 2.55, "regularMarketOpen": 2.52, "regularMarketDayLow": 2.41, "regularMarketDayHigh": 2.565, "payoutRatio": 0.0, "beta": 1.156, "forwardPE": -2.122807, "volume": 3891568, "regularMarketVolume": 3891568, "averageVolume": 1570675, "averageVolume10days": 2025360, "averageDailyVolume10Day": 2025360, "bid": 2.4, "ask": 2.44, "bidSize": 4, "askSize": 14, "marketCap": 265926544, "fiftyTwoWeekLow": 1.285, "fiftyTwoWeekHigh": 7.85, "fiftyDayAverage": 2.3884, "twoHundredDayAverage": 2.903625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 66538628, "profitMargins": 0.0, "floatShares": 89056515, "sharesOutstanding": 109887000, "sharesShort": 10136355, "sharesShortPriorMonth": 9608251, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0922, "heldPercentInsiders": 0.00424, "heldPercentInstitutions": 1.0005001, "shortRatio": 8.69, "shortPercentOfFloat": 0.115200005, "impliedSharesOutstanding": 109887000, "bookValue": 1.812, "priceToBook": 1.3355409, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -188783008, "trailingEps": -1.29, "forwardEps": -1.14, "enterpriseToEbitda": -0.335, "52WeekChange": -0.661775, "SandP52WeekChange": 0.16885936, "quoteType": "EQUITY", "currentPrice": 2.42, "targetHighPrice": 14.0, "targetLowPrice": 9.0, "targetMeanPrice": 11.6, "targetMedianPrice": 11.0, "recommendationKey": "none", "numberOfAnalystOpinions": 5, "totalCash": 227016992, "totalCashPerShare": 2.066, "ebitda": -198900000, "totalDebt": 27630000, "quickRatio": 5.586, "currentRatio": 5.674, "debtToEquity": 13.883, "returnOnAssets": -0.37473, "returnOnEquity": -0.66748, "freeCashflow": -79705504, "operatingCashflow": -156156000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Annexon, Inc.", "longName": "Annexon, Inc.", "fiftyTwoWeekLowChange": 1.1350001, "fiftyTwoWeekLowChangePercent": 0.8832686, "fiftyTwoWeekRange": "1.285 - 7.85", "fiftyTwoWeekHighChange": -5.43, "fiftyTwoWeekHighChangePercent": -0.6917197, "fiftyTwoWeekChangePercent": -66.1775, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.29, "epsForward": -1.14, "epsCurrentYear": -1.40256, "priceEpsCurrentYear": -1.7254164, "corporateActions": [], "postMarketTime": 1757719891, "regularMarketTime": 1757707201, "exchange": "NMS", "messageBoardId": "finmb_279883519", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "marketState": "CLOSED", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -5.09803, "regularMarketPrice": 2.42, "fiftyDayAverageChange": 0.0316, "fiftyDayAverageChangePercent": 0.013230613, "twoHundredDayAverageChange": -0.48362494, "twoHundredDayAverageChangePercent": -0.16655903, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1595597400000, "postMarketChangePercent": -0.41322273, "postMarketPrice": 2.41, "postMarketChange": -0.00999999, "regularMarketChange": -0.13, "regularMarketDayRange": "2.41 - 2.565", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1570675, "displayName": "Annexon", "trailingPegRatio": null, "__fetch_time": "2025-09-13"}]